Kyverna Therapeutics Inc.

NASDAQ: KYTX · Real-Time Price · USD
3.41
0.47 (15.99%)
At close: Jun 06, 2025, 3:59 PM
3.43
0.59%
After-hours: Jun 06, 2025, 05:00 PM EDT

Kyverna Therapeutics Statistics

Share Statistics

Kyverna Therapeutics has 43.22M shares outstanding. The number of shares has increased by 0.23% in one year.

43.22M
0.23%
0.1%
66.01%
n/a
2,252
0.73%

Short Selling Information

The latest short interest is 2.58M, so 5.97% of the outstanding shares have been sold short.

2.58M
5.97%
10.39%
11.4

Valuation Ratios

The PE ratio is -1.12 and the forward PE ratio is -0.91. Kyverna Therapeutics's PEG ratio is 0.

-1.12
-0.91
0
0.9
0.54
-1.23
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Kyverna Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 8.61, with a Debt / Equity ratio of 0.03.

8.61
8.61
0.03
-0.06
-0.07
-1004.25

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1,138,187.5
112
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -78.29% in the last 52 weeks. The beta is 2.54, so Kyverna Therapeutics's price volatility has been higher than the market average.

2.54
-78.29%
2.21
3.98
65.56
309,190

Income Statement

n/a
n/a
-142.6M
-127.48M
-142.6M
-127.62M
-3.33
Full Income Statement

Balance Sheet

The company has 96.62M in cash and 8.24M in debt, giving a net cash position of 88.38M.

96.62M
8.24M
88.38M
-263.52M
260.65M
214.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -114.25M and capital expenditures -2.21M, giving a free cash flow of -116.45M.

-114.25M
-2.21M
-116.45M
-3.04
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

KYTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for KYTX is $20, which is 580.3% higher than the current price. The consensus rating is "Buy".

$20
580.3%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-0.69
1